In humans, heterozygous mutations of ribosomal proteins can cause severe developmental defects, such as Diamond–Blackfan anaemia. In contrast, the DrosophilaMinute mutants, which may carry any one of a selection of ribosomal protein mutations, are phenotypically largely normal, suggesting they have mechanisms to counteract the loss of ribosomal protein activity. Now, Tatsushi Igaki and colleagues investigate the mechanisms by which Drosophila maintains morphogenesis in Minute mutants. Using a genetic screen, they find that heterozygosity for the Hippo pathway effector Yki leads to severe developmental defects in a background of heterozygous RpS3 (RpS3/+) or other ribosomal proteins. These defects are primarily caused by increased rates of apoptosis along the anteroposterior boundary in the wing discs of RpS3/+ yki/+ flies, which result from elevated JNK signalling. The authors further reveal that the caspase inhibitor DIAP1, a Yki target, shows reduced expression in the posterior compartment of RpS3/+ yki/+ wing discs. Indeed, Diap1 knockdown in the posterior or entire wing disc is sufficient to cause morphological defects in an RpS3/+ background, indicating that DIAP1 expression is the critical function of Yki in maintaining normal morphogenesis in Minute mutants. Collectively, these findings suggest that safeguarding against increased apoptosis may be a crucial step in preventing developmental defects in Minute mutants, a hypothesis that can now be investigated further in humans.
Yki protects Drosophila Minute wing discs from apoptosis
Yki protects Drosophila Minute wing discs from apoptosis. Development 15 July 2021; 148 (14): e148_e1404. doi:
Download citation file:
Advertisement
Cited by
Call for papers: Uncovering Developmental Diversity
Development invites you to submit your latest research to our upcoming special issue: Uncovering Developmental Diversity. This issue will be coordinated by our academic Editor Cassandra Extavour (Harvard University, USA) alongside two Guest Editors: Liam Dolan (Gregor Mendel Institute of Molecular Plant Biology, Austria) and Karen Sears (University of California Los Angeles, USA).
Choose Development in 2024
In this Editorial, Development Editor-in-Chief James Briscoe and Executive Editor Katherine Brown explain how you support your community by publishing in Development and how the journal champions serious science, community connections and progressive publishing.
Journal Meeting: From Stem Cells to Human Development
Register now for the 2024 Development Journal Meeting From Stem Cells to Human Development. Early-bird registration deadline: 3 May. Abstract submission deadline: 21 June.
Pluripotency of a founding field: rebranding developmental biology
This collaborative Perspective, the result of a workshop held in 2023, proposes a set of community actions to increase the visibility of the developmental biology field. The authors make recommendations for new funding streams, frameworks for collaborations and mechanisms by which members of the community can promote themselves and their research.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.